UK markets closed

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9923-0.1977 (-16.61%)
At close: 04:00PM EDT
0.9900 -0.00 (-0.23%)
After hours: 04:04PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate-0.02-0.05-0.060.09
Low estimate-0.03-0.09-0.13-0.02
High estimate00.020.040.18
Year ago EPS-0.04-0.03-0.14-0.06
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5556
Avg. Estimate33.1M37.63M148.99M192.17M
Low estimate31.56M32.31M136.4M160M
High estimate34.2M45.2M160.2M217.4M
Year ago sales26.89M27.2M116.88M148.99M
Sales growth (year/est)23.10%38.30%27.50%29.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.08-0.07-0.03-0.03
Actual EPS-0.04-0.030-0.05
Difference0.040.040.03-0.02
Surprise %50.00%57.10%100.00%-66.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.02-0.05-0.060.09
7 days ago-0.02-0.05-0.060.09
30 days ago-0.02-0.05-0.060.09
60 days ago-0.02-0.04-0.080.06
90 days ago-0.03-0.02-0.09-0.02
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRIGLIndustrySector(s)S&P 500
Current qtr.50.00%N/AN/AN/A
Next qtr.-66.70%N/AN/AN/A
Current year57.10%N/AN/AN/A
Next year250.00%N/AN/AN/A
Next 5 years (per annum)70.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A